MTOR and chronic kidney disease: In another study, CKD-induced mice observed hexosylceramide accumulation, which could cause the CKD-associated renal activation of mTOR downstream signaling, tubular injury, endoplasmic reticulum stress, fibrosis, inflammation, impaired kidney mitochondrial function, and oxidative stress [76].